Literature DB >> 12748184

Hyaluronan-mediated CD44 interaction with RhoGEF and Rho kinase promotes Grb2-associated binder-1 phosphorylation and phosphatidylinositol 3-kinase signaling leading to cytokine (macrophage-colony stimulating factor) production and breast tumor progression.

Lilly Y W Bourguignon1, Patrick A Singleton, Hongbo Zhu, Falko Diedrich.   

Abstract

In this study we have examined CD44 (a hyaluronan (HA) receptor) interaction with a RhoA-specific guanine nucleotide exchange factor (p115RhoGEF) in human metastatic breast tumor cells (MDA-MB-231 cell line). Immunoprecipitation and immunoblot analyses indicate that both CD44 and p115RhoGEF are expressed in MDA-MB-231 cells and that these two proteins are physically associated as a complex in vivo. The binding of HA to MDA-MB-231 cells stimulates p115RhoGEF-mediated RhoA signaling and Rho kinase (ROK) activity, which, in turn, increases serine/threonine phosphorylation of the adaptor protein, Gab-1 (Grb2-associated binder-1). Phosphorylated Gab-1 promotes PI 3-kinase recruitment to CD44v3. Subsequently, PI 3-kinase is activated (in particular, alpha, beta, gamma forms but not the delta form of the p110 catalytic subunit), AKT signaling occurs, the cytokine (macrophage-colony stimulating factor (M-CSF)) is produced, and tumor cell-specific phenotypes (e.g. tumor cell growth, survival and invasion) are up-regulated. Our results also demonstrate that HA/CD44-mediated oncogenic events (e.g. AKT activation, M-CSF production and breast tumor cell-specific phenotypes) can be effectively blocked by a PI 3-kinase inhibitor (LY294002). Finally, we have found that overexpression of a dominant-negative form of ROK (by transfection of MBA-MD-231 cells with the Rho-binding domain cDNA of ROK) not only inhibits HA/CD44-mediated RhoA-ROK activation and Gab-1 phosphorylation but also down-regulates oncogenic signaling events (e.g. Gab-1.PI 3-kinase-CD44v3 association, PI 3-kinase-mediated AKT activation, and M-CSF production) and tumor cell behaviors (e.g. cell growth, survival, and invasion). Taken together, these findings strongly suggest that CD44 interaction with p115RhoGEF and ROK plays a pivotal role in promoting Gab-1 phosphorylation leading to Gab-1.PI 3-kinase membrane localization, AKT signaling, and cytokine (M-CSF) production during HA-mediated breast cancer progression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12748184     DOI: 10.1074/jbc.M301885200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  92 in total

1.  Integrated genome and transcriptome sequencing identifies a novel form of hybrid and aggressive prostate cancer.

Authors:  Chunxiao Wu; Alexander W Wyatt; Anna V Lapuk; Andrew McPherson; Brian J McConeghy; Robert H Bell; Shawn Anderson; Anne Haegert; Sonal Brahmbhatt; Robert Shukin; Fan Mo; Estelle Li; Ladan Fazli; Antonio Hurtado-Coll; Edward C Jones; Yaron S Butterfield; Faraz Hach; Fereydoun Hormozdiari; Iman Hajirasouliha; Paul C Boutros; Robert G Bristow; Steven Jm Jones; Martin Hirst; Marco A Marra; Christopher A Maher; Arul M Chinnaiyan; S Cenk Sahinalp; Martin E Gleave; Stanislav V Volik; Colin C Collins
Journal:  J Pathol       Date:  2012-03-21       Impact factor: 7.996

2.  Association of cancer stem cell markers genetic variants with gallbladder cancer susceptibility, prognosis, and survival.

Authors:  Anu Yadav; Annapurna Gupta; Neeraj Rastogi; Sushma Agrawal; Ashok Kumar; Vijay Kumar; Balraj Mittal
Journal:  Tumour Biol       Date:  2015-08-30

3.  Loss of mir-146a function in hormone-refractory prostate cancer.

Authors:  Shi-Lung Lin; Angela Chiang; Donald Chang; Shao-Yao Ying
Journal:  RNA       Date:  2008-01-03       Impact factor: 4.942

4.  Association of genetic variants of cancer stem cell gene CD44 haplotypes with gallbladder cancer susceptibility in North Indian population.

Authors:  Kiran Lata Sharma; Anu Yadav; Annapurna Gupta; Sonam Tulsayan; Vijay Kumar; Sanjeev Misra; Ashok Kumar; Balraj Mittal
Journal:  Tumour Biol       Date:  2013-11-05

5.  Epsilon-aminocaproic acid prevents high glucose and insulin induced-invasiveness in MDA-MB-231 breast cancer cells, modulating the plasminogen activator system.

Authors:  Rubí Viedma-Rodríguez; María Guadalupe Martínez-Hernández; Luis Antonio Flores-López; Luis Arturo Baiza-Gutman
Journal:  Mol Cell Biochem       Date:  2017-06-13       Impact factor: 3.396

6.  Reduction of hyaluronan-CD44-mediated growth, migration, and cisplatin resistance in head and neck cancer due to inhibition of Rho kinase and PI-3 kinase signaling.

Authors:  Carlos Torre; Steven J Wang; Weiliang Xia; Lilly Y W Bourguignon
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2010-05

7.  Self-organization of engineered epithelial tubules by differential cellular motility.

Authors:  Hidetoshi Mori; Nikolce Gjorevski; Jamie L Inman; Mina J Bissell; Celeste M Nelson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-18       Impact factor: 11.205

8.  Clinical significance of pAKT and CD44v6 overexpression with breast cancer.

Authors:  Pei Yu; Ling Zhou; Weifeng Ke; Ke Li
Journal:  J Cancer Res Clin Oncol       Date:  2010-02-16       Impact factor: 4.553

Review 9.  Matrix hyaluronan-activated CD44 signaling promotes keratinocyte activities and improves abnormal epidermal functions.

Authors:  Lilly Y W Bourguignon
Journal:  Am J Pathol       Date:  2014-05-09       Impact factor: 4.307

Review 10.  Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression.

Authors:  Lilly Y W Bourguignon
Journal:  Semin Cancer Biol       Date:  2008-03-26       Impact factor: 15.707

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.